Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion type Assertion NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_head.
- NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion description "[Furthermore, prenatal administration of a MEK inhibitor ameliorated the embryonic lethality, cardiac defects, and NS features of the homozygous mutant mice, demonstrating that this signaling pathway might represent a promising therapeutic target for NS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_provenance.
- NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion evidence source_evidence_literature NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_provenance.
- NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion SIO_000772 21041952 NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_provenance.
- NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion wasDerivedFrom befree-2016 NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_provenance.
- NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_assertion wasGeneratedBy ECO_0000203 NP849703.RACmu4pt5p882D6BZQ-WKb-S955LHfqRMHOR-MrJh6x_w130_provenance.